Significo builds health-AI and digital therapeutic solutions aimed at delivering clinically validated, personalized care at scale. Its flagship offerings include Balm, a digital therapeutic delivery and reimbursement platform, and Recco, a personalized health recommendation engine. The company partners with insurers, health systems, employers, and distribution networks to improve patient engagement and population-level outcomes. With a newly announced $100 million valuation, Significo plans to accelerate growth through strategic acquisitions that consolidate fragmented digital health tools into a single, comprehensive platform. Management states that integrating complementary digital health companies will simplify technology adoption for healthcare providers. The fresh capital will also fund product development and global expansion initiatives. The company has recently recorded strong commercial traction, securing multiple partnerships across the healthcare ecosystem. Headquartered in Austin, Texas, Significo aims to make digital therapeutics more accessible, effective, and seamlessly integrated into everyday care.

Total raised

$12M

Funding rounds

2

Latest round

Series A

Latest activity

Jun 2023